DRKS00003864已完成不适用
Stereotactic ablative radiotherapy (SABR) for small lung tumors: retrospective analysis 2009-2010 - SABR
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde0 个研究点目标入组 39 人开始时间: 2016年2月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •presence of one or two FDG-PET positive pulmonary nodules - Karnofsky index >/= 60%
- •- Life expectancy > 6 months
- •- Age > 18 years (no other age limits)
- •- Informed consent signed in accordance with institutional protocol
排除标准
- •- NSCLC: FDG-PET N+ if not ruled out by mediastinoscopy or other tissue sampling
- •- in metastases: disseminated progressive disease without local control to be reasonably expected by current treatment
- •- Histologically proven SCLC
- •- More than two lesions to treat
- •- Diameter of tumor > 5cm
- •- Systemic therapy +/- one week of treatment
- •- psychological/mental status does not allow informed consent and participation in QoL assessments
- •- Pregnancy
研究者
相似试验
撤回
2 期
Stereotactic ablative radiotherapy (SABR) after systemic antineoplastic treatment for patients with unresectable oligometastases (lung; liver; adrenal glands) from solid tumours: SARASTRO Trial (Stereotactic Ablative Radiotherapy After Systemic TReatment for Oligometastases) A randomised phase II trialmetastasesspread out cancer10027476NL-OMON37714niversitair Medisch Centrum Groningen80
已完成
2 期
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
进行中（未招募）
2 期
High dose Radiation therapy to eradicate early metastatic prostate cancer as an alternative to hormone or chemotherapy: a prospective phase II studyProstate CancerACTRN12618000566235Integrated Clinical Oncology Network Pty Ltd (ICON)208
进行中（未招募）
2 期
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)Metastatic TumorsNCT01446744Lawson Health Research Institute99
撤回
2 期
ungTech Stereotactic Body Radiotherapy (SBRT) of inoperable centrally located NSCLC: A phase II study in preparation for a randomized phase III trialNon-small-cell lung cancer10038666Lung CancerNL-OMON40781European Organisation for Research in Treatment of Cancer (EORTC)42